Heart failure secondary to levantinib. An atypical event: Case Report. Rev Med Trujillo [Internet]. 2025 Dec. 5 [cited 2026 Jul. 19];20(2):079-81. Available from: https://revistas.unitru.edu.pe/index.php/RMT/article/view/6828